Patents by Inventor Miri MARKOVICH

Miri MARKOVICH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190175953
    Abstract: A method of a radiotherapy or radiosurgery treatment comprises steps of: (a) providing a converging x-ray beam source configured for emitting a converging X-ray beam propagating along an axis thereof; (b) emitting the converging x-ray beam towards a volume of treatment (VOT) having a length along the axis of the converging X-ray beam ranging between 2 mm and 5 cm within a patient's body such that a waist portion is within the VOT; (c) propagating the beam through tissues previously located relative to the VOT (PO); the VOT per se and tissues distally located to the VOT (DO). The converging X-ray beam characterized by a convergent angle ranging between 2 and 30 degrees providing 80% to 100% of a maximum dose is received by the VOT and less than 60% of the maximum dose is received by the PO and the DO.
    Type: Application
    Filed: January 27, 2019
    Publication date: June 13, 2019
    Applicant: CONVERGENT R.N.R LTD
    Inventors: Aharon BAR-DAVID, Miri MARKOVICH, Zeev BURSHTEIN, Zeev HAREL
  • Patent number: 10265510
    Abstract: The present invention provides a method for activating a pro-drug in vivo comprising the steps of: (a) administering a pro-drag to a subject; (b) locating a target site which has been at least partially dosed with the pro-drug at a predetermined concentration; and (d) exposing the target site to X-ray radiation. The step of exposing the target site to X-ray radiation is characterized by providing a converging X-ray of a controllable waist, substantially uniform at the target site, sufficient to convert the pro-drug to an active drug, while the X-ray photon dosage at the target site is higher than the X-ray photon dosage at an adjacent non target site.
    Type: Grant
    Filed: August 12, 2015
    Date of Patent: April 23, 2019
    Assignee: CONVERGENT R.N.R LTD
    Inventors: Zeev Harel, Zeev Burshtein, Aharon Bar-David, Miri Markovich
  • Publication number: 20180133513
    Abstract: A standard of care protocol for increasing efficiency of a radiotherapy or radiosurgery treatment and reducing the treatment's side effects by radiating with a converging x-ray beam source emitting a converging x-ray beam (102) towards at least one volume of treatment (VOT) (103) within a patient's body; the beam is passing through at least one organ preceding said VOT (PO) (105) and at least one organ distal to said VOT (DO) (106); the VOT is receiving, on average, at least 80% of maximum dose whilst thr PO and DO are receiving, on average, no more than 40% of the maximum dose.
    Type: Application
    Filed: December 7, 2014
    Publication date: May 17, 2018
    Applicant: CONVERGENT R.N.R LTD
    Inventors: Aharon BAR-DAVID, Miri MARKOVICH, Zeev BURSHTEIN, Zeev HAREL
  • Publication number: 20180033513
    Abstract: An X-ray system for providing a converging X-rays comprising: (a) an X-ray source having an optical axis thereof; (b) an X-ray lens arrangement comprising at least one first ring having a first Bragg reflecting surface formed by a plurality of tiles made from single crystal. At least one ring is provided with at least one second ring mounted adjacently thereto along said optical axis in a coaxial manner; said second ring has a second Bragg reflecting surface reflecting surface thereof.
    Type: Application
    Filed: June 30, 2017
    Publication date: February 1, 2018
    Applicant: Convergent R.N.R Ltd.
    Inventors: Aharon BAR-DAVID, Miri MARKOVICH, Avigail KELLER, Zeev BURSHTEIN, Zeev HAREL
  • Publication number: 20170232245
    Abstract: The present invention provides a method for activating a pro-drug in vivo comprising the steps of: (a) administering a pro-drag to a subject; (b) locating a target site which has been at least partially dosed with the pro-drug at a predetermined concentration; and (d) exposing the target site to X-ray radiation. The step of exposing the target site to X-ray radiation is characterized by providing a converging X-ray of a controllable waist, substantially uniform at the target site, sufficient to convert the pro-drug to an active drug, whilst the X-ray photon dosage at the target site is higher than the X-ray photon dosage at an adjacent non target site.
    Type: Application
    Filed: August 12, 2015
    Publication date: August 17, 2017
    Applicant: CONVERGENT R.N.R LTD
    Inventors: Zeev HAREL, Zeev BURSHTEIN, Aharon BAR-DAVID, Miri MARKOVICH